Search results
The NFL schedule-makers have the Chiefs playing on every day but Tuesday next season
Associated Press· 5 days agoWith their record-setting quarterback and pop-star dating tight end, the Kansas City Chiefs were the...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoRead about Ionis Pharmaceuticals, Roche and more in the latest Market Talks covering the Health Care sector.
The NFL schedule-makers have the Chiefs playing on every day but Tuesday next season
Seattle Times· 5 days agoWith their record-setting quarterback and pop-star dating tight end, the Kansas City Chiefs were the...
Petersen & Tietz Florists and Greenhouses to celebrate 90th anniversary this weekend
Waterloo-Cedar Falls Courier· 5 days agoThe seeds of success for the family-owned flower shop and greenhouses were sown nine decades ago. On...
Sarno, Eagles handle Lancers in annual ALS Awareness game
The Salem News· 5 days agoA global icon for patient’s rights, positivity and fighting for an ALS cure through the Ice Bucket...
This Date in Baseball - Joe DiMaggio began his 56-game hitting streak
Associated Press· 7 days ago1918 — Washington’s Walter Johnson pitched a 1-0, 18-inning victory over Lefty Williams of the...
ALS Awareness Month: Young woman's journey with new ALS treatment
Fox local via AOL· 6 days agoALS or amyotrophic lateral sclerosis is a neurological disease that robs people of using every muscle in their body, affecting their ability to walk, breathe, and eat. It typically occurs later ...
Pulitzer winner Jonathan Eig talks about how his time in Louisiana shaped his career
The Advocate· 7 days agoOn May 6, Jonathan Eig won the Pulitzer Prize for his book "King: A Life."
ALS Fundraiser was a big hit for Staten Island man who suffers from the disease
Staten Island Advance· 7 days agoA yearlong preparation for Chris Scandaglia’s 5th Annual ALS Fundraiser culminated in a big way...
REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
Reuters via Yahoo Finance· 5 days agoBiogen and Ionis Pharmaceuticals said on Thursday they will terminate the development of their experimental treatment for amyotrophic lateral sclerosis (ALS) after failing to show improvement ...